Literature DB >> 9824570

Age and Helicobacter pylori decrease gastric mucosal surface hydrophobicity independently.

A Hackelsberger1, U Platzer, M Nilius, V Schultze, T Günther, J E Dominguez-Muñoz, P Malfertheiner.   

Abstract

BACKGROUND: Gastric mucosal surface hydrophobicity (GMSH) is an essential component of the mucosal defence system that is decreased by Helicobacter pylori and non-steroidal anti-inflammatory drugs (NSAIDs). Gastric ulcers occur predominantly in elderly subjects, and may thus reflect diminished mucosal resistance. AIMS: To investigate whether aging decreases GMSH. PATIENTS: One hundred and twenty patients without peptic ulcer disease were divided into three age groups: I (41 years or below); II (41-64 years); and III (65 years or above).
METHODS: Biopsy specimens were taken from the antrum, corpus, and cardia for histology (Sydney system), urease testing for H pylori, and for contact angle measurement of GMSH with a goniometer. The presence of specific H pylori antibodies was checked by immunoblotting.
RESULTS: Fifty two patients (43%) were infected, and 68 were uninfected with H pylori. GMSH at all biopsy sites was lower in H pylori infected subjects (p=0.0001), but also decreased with age independently of infection status (p=0.0001). The most notable decrease in GMSH occurred between age groups I and II in those with, and between age groups II and III in those without, H pylori infection. GMSH was greater in antral than in corpus mucosa in both infected (p=0.0001) and uninfected patients (p=0.0003).
CONCLUSIONS: A physiological decrease in GMSH with aging may contribute to the risk of ulcer development in the elderly, and may act synergistically with H pylori and/or NSAIDs on gastric mucosal defence.

Entities:  

Mesh:

Year:  1998        PMID: 9824570      PMCID: PMC1727283          DOI: 10.1136/gut.43.4.465

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  39 in total

1.  Healing of acetic acid-induced gastric ulcer and gastric mucosal PGI2 level in rats.

Authors:  M Uchida; O Kawano; N Misaki; K Saitoh; O Irino
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

2.  Localization of phospholipid-rich zones in rat gastric mucosa: possible origin of a protective hydrophobic luminal lining.

Authors:  Y C Kao; L M Lichtenberger
Journal:  J Histochem Cytochem       Date:  1987-11       Impact factor: 2.479

3.  Surface hydrophobicity of the gastric mucosa in the developing rat. Effects of corticosteroids, thyroxine, and prostaglandin E2.

Authors:  E J Dial; L M Lichtenberger
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

4.  Measurement of the surface hydrophobicity of human gastrointestinal mucosa.

Authors:  R T Spychal; J M Marrero; S H Saverymuttu; T C Northfield
Journal:  Gastroenterology       Date:  1989-07       Impact factor: 22.682

5.  A role for milk phospholipids in protection against gastric acid. Studies in adult and suckling rats.

Authors:  E J Dial; L M Lichtenberger
Journal:  Gastroenterology       Date:  1984-08       Impact factor: 22.682

6.  Milk protection against experimental ulcerogenesis in rats.

Authors:  E J Dial; L M Lichtenberger
Journal:  Dig Dis Sci       Date:  1987-10       Impact factor: 3.199

7.  Chronic gastritis and gastroduodenal ulcer: a case control study on risk of coexisting duodenal or gastric ulcer in patients with gastritis.

Authors:  P Sipponen; K Seppälä; M Aärynen; T Helske; P Kettunen
Journal:  Gut       Date:  1989-07       Impact factor: 23.059

8.  Does aspirin damage canine gastric mucosa by reducing its surface hydrophobicity?

Authors:  P J Goddard; B A Hills; L M Lichtenberger
Journal:  Am J Physiol       Date:  1987-03

Review 9.  Ulcer epidemiology: an overview and proposed research framework.

Authors:  J H Kurata
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

10.  Effect of 16,16-dimethyl prostaglandin E2 on the surface hydrophobicity of aspirin-treated canine gastric mucosa.

Authors:  L M Lichtenberger; J E Richards; B A Hills
Journal:  Gastroenterology       Date:  1985-01       Impact factor: 22.682

View more
  9 in total

Review 1.  Effect of age-related changes in gastric physiology on tolerability of medications for older people.

Authors:  Julia L Newton
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  Characterization of virulence factors of mouse-adapted Helicobacter pylori strain SS1 and effects on gastric hydrophobicity.

Authors:  A S Day; N L Jones; Z Policova; H A Jennings; E K Yau; P Shannon; A W Neumann; P M Sherman
Journal:  Dig Dis Sci       Date:  2001-09       Impact factor: 3.199

3.  Reduced hydrophobicity of the colonic mucosal surface in ulcerative colitis as a hint at a physicochemical barrier defect.

Authors:  Annika Braun; Ulrike Schönfeld; Thilo Welsch; Martina Kadmon; Benjamin Funke; Daniel Gotthardt; Alexandra Zahn; Frank Autschbach; Peter Kienle; Michael Zharnikov; Michael Grunze; Wolfgang Stremmel; Robert Ehehalt
Journal:  Int J Colorectal Dis       Date:  2011-04-01       Impact factor: 2.571

Review 4.  Helicobacter pylori-associated peptic ulcer disease in older patients: current management strategies.

Authors:  A Pilotto
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

5.  N-acetylcysteine, a novel treatment for Helicobacter pylori infection.

Authors:  Hien Quoc Huynh; Richard T L Couper; Cuong D Tran; Lynette Moore; Richard Kelso; Ross N Butler
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

6.  Clinical trial: comparison of ibuprofen-phosphatidylcholine and ibuprofen on the gastrointestinal safety and analgesic efficacy in osteoarthritic patients.

Authors:  F L Lanza; U K Marathi; B S Anand; L M Lichtenberger
Journal:  Aliment Pharmacol Ther       Date:  2008-06-11       Impact factor: 8.171

7.  Bio-physical characteristics of gastrointestinal mucosa of celiac patients: comparison with control subjects and effect of gluten free diet-.

Authors:  Stefania Bertolazzi; Francesco Lanzarotto; Barbara Zanini; Chiara Ricci; Vincenzo Villanacci; Alberto Lanzini
Journal:  BMC Gastroenterol       Date:  2011-11-07       Impact factor: 3.067

Review 8.  Improving the gastrointestinal tolerability of aspirin in older people.

Authors:  Julia L Newton
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

9.  Advent of novel phosphatidylcholine-associated nonsteroidal anti-inflammatory drugs with improved gastrointestinal safety.

Authors:  Yun Jeong Lim; Elizabeth J Dial; Lenard M Lichtenberger
Journal:  Gut Liver       Date:  2012-11-13       Impact factor: 4.519

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.